| Identification | Back Directory | [Name]
BOC-D-TRYPTOPHANOL | [CAS]
158932-00-4 | [Synonyms]
BOC-D-TRP-OL
BOC-D-TRYPTOPHANOL
BOC-D-Trypthophanol
N-BOC-D-TRYPTOPHANOL
N-T-BOC-D-TRYPTOPHANOL
N-alpha-Boc-D-tryptophanol
BOC-D-TRYPTOPHANOL USP/EP/BP
N-ALPHA-T-BOC-D-TRYPTOPHANOL
N(^a)-Boc-D-tryptophanol, 98%
N-Boc-D- coloraMMonia alcohol
Boc-D-Tryptophanol≥ 99% (HPLC)
N-α-Boc-D-tryptophanol,98%e.e.
BOC-(R)-2-AMINO-3-(3-INDOLYL)-1-PROPANOL
N-alpha-t-Butyloxycarbonyl-D-tryptophanol
(R)-tert-Butyl (1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)carbaMate
tert-butyl N-[(2R)-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]carbamate
(R)-[2-Hydroxy-1-(1H-indol-3-ylmethyl)ethyl]carbamic acid tert-butyl ester
(2R)-2-{[(tert-butoxy)carbonyl]aMino}-3-(2-hydroxy-1H-indol-3-yl)propanoic acid
Carbamic acid, N-[(1R)-2-hydroxy-1-(1H-indol-3-ylmethyl)ethyl]-, 1,1-dimethylethyl ester
N-[3-(1H-indol-3-yl)-1-methoxy-1-oxopropan-2-yl]-[[5-(5-methyl-2,4-dioxopyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methoxy]phosphonamidic acid
[5-(2,4-diketo-5-methyl-pyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methoxy-N-[1-(1H-indol-3-ylmethyl)-2-keto-2-methoxy-ethyl]phosphonamidic acid
N-[3-(1H-indol-3-yl)-1-methoxy-1-oxo-propan-2-yl]-[[5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methoxy]phosphonamidic acid | [Molecular Formula]
C16H22N2O3 | [MDL Number]
MFCD00270221 | [MOL File]
158932-00-4.mol | [Molecular Weight]
290.36 |
| Chemical Properties | Back Directory | [Melting point ]
119-121℃ | [Boiling point ]
518.1±45.0 °C(Predicted) | [density ]
1.190 | [storage temp. ]
under inert gas (nitrogen or Argon) at 2–8 °C | [solubility ]
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | [form ]
Powder | [pka]
12.06±0.46(Predicted) | [Appearance]
White to off-white Solid |
| Hazard Information | Back Directory | [Chemical Properties]
White solid | [Synthesis]
General procedure for the synthesis of N-Boc-D-tryptophan from Boc-D-tryptophan: a) Synthesis of compound 22; Compound 1 (Boc-D-tryptophan, 10.0 g, 33 mmol) was dissolved in THF (50 mL), cooled to 0 °C under nitrogen atmosphere, and then BH3/THF solution was slowly added dropwise. The reaction mixture was gradually warmed to room temperature and stirred continuously for 16 hours. Upon completion of the reaction, the reaction was quenched with aqueous potassium carbonate and subsequently extracted with ethyl acetate (100 mL x 3). The organic phases were combined, washed with brine (50 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification by column chromatography (petroleum ether/ethyl acetate=4:1) afforded the product 22 (N-Boc-D-chromanol) as a white solid (5.72 g, 60% yield).1H NMR (400 MHz, CDCl3): δ1.46 (s, 9H), 3.02 (d, J=6.8 Hz, 2H), 3.80-3.55 (m, 2H). 4.10-3.95 (m, 1H), 4.86 (br s, 1H), 7.07 (s, 1H), 7.16 (t, J=7.2Hz, 1H), 7.23 (t, J=7.2Hz, 1H), 7.39 (d, J=8.4Hz, 1H), 7.68 (d, J=7.6Hz, 1H), 8.20 (s, 1H). | [References]
[1] ChemMedChem, 2016, p. 1924 - 1935
[2] Patent: WO2012/55945, 2012, A1. Location in patent: Page/Page column 23
[3] Journal of Medicinal Chemistry, 1994, vol. 37, # 13, p. 2011 - 2032 |
|
|